These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16130187)

  • 21. Comparison of time course of neuromuscular blockade in young children following rocuronium and atracurium.
    Ribeiro FC; Scheiber G; Marichal A
    Eur J Anaesthesiol; 1998 May; 15(3):310-3. PubMed ID: 9649990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
    McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
    Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases.
    McCoy EP; Mirakhur RK; Maddineni VR; Loan PB; Connolly F
    Anaesthesia; 1994 Nov; 49(11):940-5. PubMed ID: 7802236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter trial of prolonged infusions of rocuronium bromide in critically ill patients: effects of multiple organ failure.
    Circeo LE; Reeves ST
    South Med J; 2001 Jan; 94(1):36-42. PubMed ID: 11213940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium.
    Adamus M; Gabrhelik T; Marek O
    Eur J Anaesthesiol; 2008 Jul; 25(7):589-95. PubMed ID: 18405411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking does not alter the dose-requirements and the pharmacodynamics of rocuronium.
    Pühringer FK; Keller P; Löckinger A; Kleinsasser A; Scheller A; Raedler C; Keller C
    Can J Anaesth; 2000 Apr; 47(4):347-9. PubMed ID: 10764181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of rocuronium during the three stages of liver transplantation.
    Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD
    Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cis-atracurium requirements during prolonged administration to a child.
    Tobias JD
    Can J Anaesth; 1997 Jan; 44(1):82-4. PubMed ID: 8988829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous infusion of rocuronium in a paediatric intensive care unit.
    Tobias JD
    Can J Anaesth; 1996 Apr; 43(4):353-7. PubMed ID: 8697549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of tubocurarine, rocuronium, and cisatracurium in the prevention and reduction of succinylcholine-induced muscle fasciculations.
    True CA; Carter PJ
    AANA J; 2003 Feb; 71(1):23-8. PubMed ID: 12776646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
    Kocabas S; Yedicocuklu D; Askar FZ
    Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass.
    Cammu G; Coddens J; Hendrickx J; Deloof T
    Br J Anaesth; 2000 May; 84(5):587-90. PubMed ID: 10844834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target controlled infusion of rocuronium: selection of a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V; Adriaensen HF
    Acta Anaesthesiol Belg; 2002; 53(1):17-9. PubMed ID: 11975424
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of continuous infusion of vecuronium and atracurium in midline and paramedian laparotomies.
    Chaudhari LS; Shetty AN; Buddhi M; Krishnan G
    J Postgrad Med; 1999; 45(1):5-9. PubMed ID: 10734323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.